Silence Therapeutics (SLN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist

17.300
-0.040-0.23%

Close Oct 31 16:00 ET

17.300
0.0000.00%

Post 16:00 ET

809.60MMarket Cap-13675P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash Wisely
Yahoo FinanceOct 28 12:41 ET
Express News | Silence Therapeutics - From Time to Time, Co or Any Selling Shareholder May Offer and Sell Ordinary Shares
ReutersOct 22 17:23 ET
Express News | Silence Therapeutics PLC Files for Stock Shelf; Size Not Disclosed - SEC Filing
ReutersOct 22 17:21 ET
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT NewswiresOct 14 11:11 ET
AstraZeneca Deal Has Positive Read for Silence Therapeutics, Says Morgan Stanley
TipRanksOct 8 07:00 ET
Silence Therapeutics Insider Ups Holding During Year
Simply Wall StOct 4 06:38 ET

Comments

Moomoo AI

Feb 3 06:08

Despite strong growth, Silence Therapeutics' high P/S ratio and weak revenue outlook suggest a risk of share price decline. Analysts lack confidence in a business turnaround, indicating potential risk for shareholders and potential investors.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 26% But Growth Is Lacking

Moomoo AI

Nov 27, 2023 04:17

Analysts' confidence appears low for Silence Therapeutics' business turnaround. The high P/S ratio and expected revenue decline suggest unsustainable current price levels which may erode current sentiment towards the stock.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 65% But Growth Is Lacking

Trytosaveabit

Nov 1, 2023 06:13

News

$Silence Therapeutics (SLN.US)$ Silence Therapeutics Reports Topline Results From Phase 1 Multiple Dose Study Of Zerlasiran; Lp(a) Levels Remained Around 90% Lower Than Baseline At Study Endpoint